Despite growing reports of serious and even fatal reactions to
the human papillomavirus (HPV) vaccine, the U.S. Citizenship and
Immigration Services (USCIS) announced today that people from other
countries who want to become legal permanent residents of the U.S.
are required to have the HPV vaccination to protect against cervical
cancer.
The new rule, outlined in the Centers for Disease Control's (CDC)
revised Technical Instructions to Civil Surgeons for Vaccination
Requirements, stipulates "age-appropriate" groups, which means
girls and young adult women, have to show proof of the vaccinations
or they will not be granted legal permanent resident status in the
U.S.
This marks another enormous marketing success for the drug giant
Merck & Co., maker
of the HPV vaccine,
Gardasil. Merck has lobbied for virtual universal vaccination
of females with the vaccine. Gardasil
is currently licensed for use in girls and women ages 9 to 26 and
many health and
school officials are pushing to make the vaccine mandatory
for all girls by the age of 11 or 12. Some doctors are also offering
Gardasil "off label" to women in their 20s to "catch-up" on their
vaccinations. Merck, whose profits from the vaccine are expected
to be in the billions, also wants to market it to women ages 27
to 45. So far the U.S. Food and Drug Administration has denied that
request.
The rationale for the current push in this country as well as in
Europe to immunize against the HPV
virus is the claim it protects women from developing HPV-caused
genital warts and, most importantly, cervical
cancer (and other even more rare malignancies of the female
reproductive tract). However, a look at the statistics -- and risks
associated with taking the vaccine -- raise some common sense questions
about both the safety and efficacy of Gardasil.
For example, the American Cancer Society estimates that in 2008,
11,070 women will be diagnosed with cervical cancer
in this country. With early detection, cervical cancer is highly
treatable and curable. But the HPV vaccine, Gardasil, has only been
on the market since 2006 and has already been responsible for thousands
of documented severe side
effects, including numerous deaths.
Judicial Watch, a public interest group, says the most recent reports
show the vaccine has caused 21 deaths and 9,749 adverse reactions,
including 78 outbreaks of the genital warts it is supposed to protect
against, as well as 10 miscarriages.
And this may be the tip of the serious side effect iceberg when
it comes to Gardasil: A study published in the New England Journal
of Medicine concludes only about 10% of actual side effects
end up being reported to the Vaccine Adverse Event Reporting System
(VAERS).
There is mounting evidence Gardasil isn't even particularly effective.
The European Union, which, like the U.S.
government, is actively pushing for massive Gardasil vaccinations,
admits on its consumer health web site that "HPV vaccination is
not a replacement for routine cervical screening... no vaccine is
100% effective and HPV vaccines will not provide protection against
non-vaccine HPV types, or against existing HPV infections..."
HPV is one of the most common sexually transmitted diseases (STDs)
and close to 90 percent of all people who have sex get HPV at some
point in their lives. The more sexual partners you have, the more
likely you will contract a form of the infection. Six million Americans
are infected with HPV every year but only a tiny percentage actually
develop serious problems.
There are numerous strains of HPV yet only a few are linked to cancer.
What's more, only about 10 percent of women who do contract the
high-risk types of HPV on their cervix will develop long-lasting
HPV infections that put them at risk for cervical cancer, according
to the CDC's own web site.
The site also states: "Most infections with high-risk HPV types
do not lead to cancer. The immune
system can often remove the virus before it causes problems...
In most cases, the body fights off HPV naturally and the infected
cells then go back to normal." The CDC
experts also point out that people with HPV caused warts can use
patient-applied creams to treat them -- or just wait until they
go away on their own.
Bottom line: A non-promiscuous lifestyle and a healthy immune system
offer the best ways to guard against HPV and HPV-caused cancer.
Unfortunately, the new U.S. Citizenship and Immigration Services
ruling demanding HPV vaccinations of new legal permanent residents
of this country is another worrisome step toward government mandated
vaccinations that reduce individual health choice and freedom.









